Regulation of RANTES/CCL5 expression in human astrocytes by interleukin-1 and interferon-β

Journal of Neurochemistry

Volumn 90, Issue 2, 2004, Pages 297-308

  Kim, Mee Ohk ^a   Suh, Hyeon Sook ^a   Brosnan, Celia F ^a   Lee, Sunhee C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Brain; Chemokine; Human; Promoter; Transcription

Indexed keywords

BETA INTERFERON; BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; GAMMA INTERFERON; I KAPPA B ALPHA; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; RANTES; RECOMBINANT BETA INTERFERON; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 1BETA; RIBONUCLEASE; STAT1 PROTEIN; STAT2 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ARTICLE; ASTROCYTE; COMPLEX FORMATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENHANCER REGION; FETUS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERFERON STIMULATED RESPONSIVE ELEMENT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; REGULATORY MECHANISM; REPORTER GENE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

ASTROCYTES; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL NUCLEUS; CELLS, CULTURED; CHEMOKINES, CC; DRUG SYNERGISM; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; INTERFERON-BETA; INTERLEUKIN-1; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RANTES; RESPONSE ELEMENTS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 3142777716     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02487.x     Document Type: Article

References (67)

1. Akwa Y., Hassett D., Eloranta M. L., Sandberg K., Masliah E., Powell H., Whitton J. L., Bloom F. E. and Campbell I. L. (1998) Transgenic expression of IFNα in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J. Immunol. 161, 5016-5026.
2. Bain J., McLauchlan H., Elliott M. and Cohen P. (2003) The specificities of protein kinase inhibitors: an update. Biochem. J. 371, 199-204.
3. + T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions. Proc. Natl Acad. Sci. USA 96, 6873-6878.
4. Barnes D. A., Huston M., Holmes R., Benveniste E. N., Yong V. W., Scholz P. and Perez H. D. (1996) Induction of RANTES expression by astrocytes and astrocytoma cell lines. J. Neuroimmunol. 71, 207-214.
5. Bennett B. L., Sasaki D. T., Murray B. W. et al. (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl Acad. Sci. USA 98, 13681-13686.
6. Bhat N. R., Feinstein D. L., Shen Q. and Bhat A. N. (2002) p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells. Roles of nuclear factors, nuclear factor kappa B, cAMP response element-binding protein, CCAAT/enhancer-binding protein-beta, and activating transcription factor-2. J. Biol. Chem. 277, 29584-29592.
7. Cardinaux J. R., Allaman I. and Magistretti P. J. (2000) Pro-inflammatory cytokines induce the transcription factors C/EBPbeta and C/EBPdelta in astrocytes. Glia 29, 91-97.
8. Casola A., Garofalo R. P., Haeberle H., Elliott T. F., Lin R., Jamaluddin M. and Brasier A. R. (2001) Multiple cis regulatory elements control RANTES promoter activity in alveolar epithelial cells infected with respiratory syncytial virus. J. Virol. 75, 6428-6439.
9. Davies S. P., Reddy H., Caivano M. and Cohen P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105.
10. Dhib-Jalbut S. (1997) Mechanism of interferon beta action in multiple sclerosis. Multiple Sclerosis 3, 397-401.
11. Dragic T., Litwin V., Allaway G. P. et al. (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667-673.
12. Fitzgerald K. A., McWhirter S. M., Faia K. L., Rowe D. C., Latz E., Golenbock D. T., Coyle A. J., Liao S. M. and Maniatis T. (2003) IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491-496.
13. Genin P., Algarte M., Roof P., Lin R. and Hiscott J. (2000) Regulation of RANTES chemokine gene expression requires cooperation between NF-kB and IFN-regulatory factor transcription factors. J. Immunol. 164, 5352-5361.
14. Giri S., Jatana M., Rattan R., Won J. S., Singh I. and Singh A. K. (2002) Galactosylsphingosine (psychosine)-induced expression of cytokine-mediated inducible nitric oxide synthases via AP-1 and C/EBP: implications for Krabbe disease. FASEB J. 16, 661-672.
15. Guttridge D. C., Albanese C., Reuther J. Y., Pestell R. G. and Baldwin A. S. Jr (1999) NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19, 5785-5799.
16. Honda Y., Rogers L., Nakata K., Zhao B. Y., Pine R., Nakai Y., Kurosu K., Rom W. N. and Weiden M. (1998) Type I interferon induces inhibitory 16-kD CCAAT/enhancer binding protein (C/EBP) beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. J. Exp. Med. 188, 1255-1265.
17. Hua L. L. and Lee S. C. (2000) Distinct patterns of stimulus-inducible chemokine mRNA accumulation in human fetal astrocytes and microglia. Glia 30, 74-81.
18. Hua L. L., Liu J. S. H., Brosnan C. F. and Lee S. C. (1998) Selective inhibition of human glial inducible nitric oxide synthase expression by interferon-beta: implications for multiple sclerosis. Ann. Neurol. 43, 384-387.
19. Hua L. L., Kim M. O., Brosnan C. F. and Lee S. C. (2002a) Modulation of astrocyte inducible nitric oxide synthase and cytokine expression by IFN is associated with induction and inhibition of GAS binding activity. J. Neurochem. 83, 1120-1128.
20. Hua L. L., Zhao M.-L., Cosenza M., Kim M. O., Huang H., Tanowitz H. B., Brosnan C. F. and Lee S. C. (2002b) Role of mitogen-activated protein kinases in inducible nitric oxide synthase and TNFα expression in human fetal astrocytes. J. Neuroimmunol. 126, 180-189.
21. John G. R., Lee S. C. and Brosnan C. F. (2003) Cytokines: powerful regulators of glial cell activation. Neuroscientist 9, 10-22.
22. Joyce D., Bouzahzah B., Fu M. et al. (1999) Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway. J. Biol. Chem. 274, 25245-25249.
23. Kim M. O., Si Q., Zhou J. N., Pestell R. G., Brosnan C. F., Locker J. and Lee S. C. (2002) Interferon-beta activates multiple signaling cascades in primary human microglia. J. Neurochem. 81, 1361-1371.
24. Kitai R., Zhao M. L., Zhang N., Hua L. L. and Lee S. C. (2000) Role of MIP-1β and RANTES in HIV-1 infection of microglia: inhibition of infection and induction by IFNβ. J. Neuroimmunol. 110, 230-239.
25. Komuro I., Yokota Y., Yasuda S., Iwamoto A. and Kagawa K. S. (2003) CSF-induced and HIV-1-mediated distinct regulation of Hck and C/EBPbeta represent a heterogeneous susceptibility of monocyte-derived macrophages to M-tropic HIV-1 infection. J. Exp. Med. 198, 443-453.
26. Krebs D. L. and Hilton D. J. (2000) SOCS: physiological suppressors of cytokine signaling. J. Cell Sci. 113, 2813-2819.
27. Lee S. C. and Brosnan C. F. (1997) Molecular biology of glia: astrocytes, in Molecular Biology of Multiple Sclerosis (Russell, W. C., ed.), pp. 71-96. John Wiley & Sons, Ltd.
28. Lee S. C., Liu W., Brosnan C. F. and Dickson D. W. (1992) Characterization of human fetal dissociated CNS cultures with an emphasis on microglia. Lab. Invest. 67, 465-475.
29. Lee S. C., Liu W, Dickson D. W., Brosnan C. F. and Berman J. W. (1993a) Cytokine production by human fetal microglia and astrocytes: differential induction by LPS and IL-1β. J. Immunol. 150, 2659-2667.
30. Lee S. C., Liu W., Roth P., Dickson D. W., Berman J. W. and Brosnan C. F. (1993b) Macrophage colony stimulating factor (CSF-1) in astrocytes and microglia: differential regulation by cytokines and LPS and inhibition of class II MHC expression on microglia. J. Immunol. 150, 594-604.
31. Lee S. C., Dickson D. W. and Brosnan C. F. (1995) Interleukin-1, nitric oxide and reactive astrocytes. Brain Behav. Immun. 9, 345-354.
32. Lekstrom-Himes J. and Xanthopoulos K. G. (1998) Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J. Biol. Chem. 273, 28545-28548.
33. Li Q. Q. and Bever C. T. (2001) Th1 cytokines stimulate RANTES chemokine secretion by human astroglial cells depending on de novo transcription. Neurochem. Res. 26, 125-133.
34. Liu J., Zhao M.-L., Brosnan C. F. and Lee S. C. (1996) Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL-1β and IL-1 receptor antagonist. J. Immunol. 157, 3569-3576.
35. Liu J. S. H., Amaral T., Brosnan C. F. and Lee S. C. (1998) Interferons are critical regulators of IL-1b and IL-1ra expression in human fetal microglia. J. Immunol. 161, 1989-1996.
36. Liu H., Chao D., Nakayama E. E. et al. (1999) Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc. Natl Acad. Sci. USA 96, 4581-4585.
37. Liu J. S. H., John G. R., Sikora A., Lee S. C. and Brosnan C. F. (2000) Modulation of IL-1β and TNFα signaling by P2 purinergic receptors in human fetal astrocytes. J. Neurosci. 20, 5292-5299.
38. Liu J. S. H., Zhao M. L., Brosnan C. F. and Lee S. C. (2001) Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am. J. Pathol. 158, 2057-2066.
39. Lopez-Collazo E., Hortelano S., Rojas A. and Bosca L. (1998) Triggering of peritoneal macrophages with IFN-α/β attenuates the expression of inducible nitric oxide synthase through a decrease in NF-kB activation. J. Immunol. 160, 2889-2895.
40. Luo Y., Berman M. A., Zhai Q., Fischer F. R., Abromson-Leeman S. R., Zhang Y., Kuziel W. A., Gerard C. and Dorf M. E. (2002) RANTES stimulates inflammatory cascades and receptor modulation in murine astrocytes. Glia 39, 19-30.
41. Maniatis T., Falvo J. V., Kim T. H., Kim T. K., Lin C. H., Parekh B. S. and Wathelet M. G. (1998) Structure and function of the interferon-beta enhanceosome. Cold Spring Harb. Symp. Quant. Biol. 63, 609-620.
42. Marshall J., Dolan B. M., Garcia E. P., Sathe S., Tang X., Mao Z. and Blair L. A. (2003) Calcium channel and NMDA receptor activities differentially regulate nuclear C/EBPbeta levels to control neuronal survival. Neuron 39, 625-639.
43. Miyamoto N. G., Medberry P. S., Hesselgesser J., Boehlk S., Nelson P. J., Krensky A. M. and Perez H. D. (2000) Interleukin-1 beta induction of the chemokine RANTES promoter in the human astrocytoma line CH235 requires both constitutive and inducible transcription factors. J. Neuroimmunol. 105, 78-90.
44. Noe K. H., Cenciarelli C., Moyer S. A., Rota P. A. and Shin M. L. (1999) Requirements for measles virus induction of RANTES chemokine in human astrocytoma-derived U373 cells. J. Virol. 73, 3117-3124.
45. Oh J. W., Schwiebert L. M. and Benveniste E. N. (1999) Cytokine regulation of CC and CXC chemokine expression by human astrocytes. J. Neurovirol. 5, 82-94.
46. Ramji D. P. and Foka P. (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365, 561-575.
47. Ransohoff R. M., Devajyothi C., Estes M. L., Babcock G., Rudick R. A., Frohman E. M. and Barna B. P. (1991) Interferon-beta specifically inhibits interferon-gamma-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line. J. Neuroimmunol. 33, 103-112.
48. Sanders V. J., Pittman C. A., White M. G., Wang G., Wiley C. A. and Achim C. L. (1998) Chemokines and receptors in HIV encephalitis. AIDS 12, 1021-1026.
49. Schafer S. L., Lin R., Moore P. A., Hiscott J. and Pitha P. M. (1998) Regulation of type I interferon gene expression by interferon regulatory factor-3. J. Biol. Chem. 273, 2714-2720.
50. Schulze-Osthoff K., Ferrari D., Riehemann K. and Wesselborg S. (1997) Regulation of NF-kB activation by MAP kinase cascade. Immunobiology 198, 35-49.
51. Sharma S., TenOever B. R., Grandvaux N., Zhou G. P., Lin R. and Hiscott J. (2003) Triggering the Interferon Antiviral Response Through an IKK-Related Pathway. Science 300, 1148-1151.
52. Shrikant P., Chung I. Y., Balldestas M. E. and Benveniste E. N. (1994) Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-alpha, interleukin-1 beta, and interferon gamma in astrocytes. J. Neuroimmunol. 51, 209-220.
53. Si Q., Cosenza M., Zhao M.-L., Goldstein H. and Lee S. C. (2002a) GM-CSF and M-CSF modulate β-chemokine and HIV-1 expression in microglia. Glia 39, 174-183.
54. Si Q., Kim M. O., Zhao M.-L., Landau N. R., Goldstein H. and Lee S. C. (2002b) Vpr- and Nef-dependent induction of RANTES in microglial cells. Virology 301, 342-353.
55. Song M. M. and Shuai K. (1998) The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J. Biol. Chem. 273, 35056-35062.
56. Sorensen T. L., Tani M., Jensen J. et al. (1999) Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103, 807-815.
57. Uddin S., Majchrzak B., Woodson J., Alrunkumar P., Alsayed Y., Pine R., Young P. R., Fish N. and Platanias L. C. (1999) Activation of the p38 mitogen-activated protein kinase by type I interferons. J. Biol. Chem. 274, 30127-30131.
58. Vanden Berghe W., Plaisance S., Boone E., De Bosscher K., Schmitz M. L., Fiers W. and Haegeman G. (1998) p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273, 3285-3290.
59. Wandinger K. P., Sturzebecher C. S., Bielekova B., Detore G., Rosenwald A., Staudt L. M., McFarland H. F. and Martin R. (2001) Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes. Ann. Neurol. 50, 349-357.
60. Wang J., Schreiber R. D. and Campbell I. L. (2002) STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-alpha in the central nervous system. Proc. Natl Acad. Sci. USA 99, 16209-16214.
61. Wang J., Pham-Mitchell N., Schindler C. and Campbell I. L. (2003) Dysregulated Sonic hedgehog signaling and medulloblastoma consequent to IFN-alpha-stimulated STAT2-independent production of IFN-gamma in the brain. J. Clin. Invest. 112, 535-543.
62. Weinstock-Guttman B., Ransohoff R. M., Kinkel R. P. and Rudick R. A. (1994) The interferons: Biological effects, mechanisms of action, and use in multiple sclerosis. Ann. Neurol. 37, 7-15.
63. Williams S. C., Angerer N. D. and Johnson P. F. (1997) C/EBP proteins contain nuclear localization signals imbedded in their basic regions. Gene Expr. 6, 371-385.
64. Xiong W., Hsieh C. C., Kurtz A. J., Rabek J. P. and Papaconstantinou J. (2001) Regulation of CCAAT/enhancer-binding protein-beta isoform synthesis by alternative translational initiation at multiple AUG start sites. Nucl. Acids Res. 29, 3087-3098.
65. Yong V. W., Chabot S., Stuve O. and Williams G. (1998) Interferon beta in the treatment of multiple sclerosis: mechanisms of action. Neurology 51, 682-689.
66. Zagury D., Lachgar A., Chams V. et al. (1998) C-C chemokines, pivotal in protection against HIV type 1 infection. Proc. Natl Acad. Sci. USA 95, 3857-3861.
67. Zhao M. L., Kim M. O., Morgello S. and Lee S. C. (2001) Expression of iNOS, IL-1 and caspase-1 in HIV-1 encephalitis. J. Neuroimmunol. 115, 182-191.